Heart Concerns Shift To Aleve Following Alzheimer’s Trial
This article was originally published in The Pink Sheet Daily
Executive Summary
Preliminary data suggest long-term naproxen use caused a 50% increase in cardiovascular adverse events compared to placebo in a prematurely halted trial, which also included Pfizer's COX-2 inhibitor Celebrex (celecoxib)